)
Sanofi Consumer Healthcare India Limited (SANOFICONR) investor relations material
Sanofi Consumer Healthcare India Limited Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for Q2 2026 reached ₹2,357 million, up 7% year-over-year, with domestic sales growing 12% and export sales declining 9% on a high base.
Net profit for Q2 2026 was ₹919 million, with profit before tax up 16% year-over-year.
For the half year ended June 30, 2026, revenue from operations was ₹4,649 million, up 18% year-over-year, with domestic sales up 14% and export sales up 27% on a low base.
Profit before tax for the half year increased by 25% year-over-year.
Financial highlights
Cash and cash equivalents increased to ₹4,902 million as of June 30, 2026, from ₹3,748 million at December 31, 2025.
Net cash inflow from operating activities for H1 2026 was ₹1,096 million, compared to ₹179 million in H1 2025.
Net cash used in financing activities was ₹47 million for H1 2026, significantly lower than the ₹1,298 million outflow in H1 2025.
Outlook and guidance
Management highlighted disciplined execution and targeted investments as drivers of profitable growth and market share gains.
The company remains confident in its strategy and continues to focus on strengthening its brand portfolio.
- Strong revenue and profit growth supported by robust domestic and export sales post-relaunch.SANOFICONR
Q1 202628 Apr 2026 - Double-digit growth achieved through brand leadership, digital focus, and operational excellence.SANOFICONR
Investor presentation24 Mar 2026 - FY25 net profit rose to ₹2,401 million on revenue of ₹8,045 million; ₹75/share dividend proposed.SANOFICONR
Q4 202525 Feb 2026 - Half-year net profit was ₹917 million, with results shaped by demerger and product recalls.SANOFICONR
Q2 202418 Feb 2026 - Q3 2024 revenue reached ₹1,599 million, with net profit at ₹450 million amid product recalls.SANOFICONR
Q3 202418 Feb 2026 - FY 2024 net profit reached ₹1,810 million, with strong core portfolio performance and a ₹55 dividend.SANOFICONR
Q4 202418 Feb 2026 - Q1 2025 net profit fell to ₹500 million amid product recalls; Depura Adult relaunched.SANOFICONR
Q1 202518 Feb 2026 - Q2 2025 revenue up 28% YoY and profit after tax up 21%, led by launches and export growth.SANOFICONR
Q2 202518 Feb 2026 - Q3 2025 revenue up 46% and net profit up 40% year-over-year, with all recalled products relaunched.SANOFICONR
Q3 202518 Feb 2026
Next Sanofi Consumer Healthcare India Limited earnings date
Next Sanofi Consumer Healthcare India Limited earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)